sellWeak10b5-1 plan
Patrice Louvet sold $5.5M of RL
President and CEO at RALPH LAUREN CORP. 24,000 shares at an average of $227.16, traded Dec 11, 2024, filed Dec 13, 2024.
Warning score
35Value
$5.5M
24,000 shares
Holdings after
112,049
-18% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +25Trade size$5.5M at market
- +5Share of holdings soldSold 18% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950142-24-002943, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -4,617 | $225.56 | $1.0M | 131,432 | Dec 13, 2024 |
| Dec 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -4,217 | $226.47 | $955k | 127,215 | Dec 13, 2024 |
| Dec 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -9,117 | $227.48 | $2.1M | 118,098 | Dec 13, 2024 |
| Dec 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -5,891 | $228.36 | $1.3M | 112,207 | Dec 13, 2024 |
| Dec 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -158 | $229.52 | $36k | 112,049 | Dec 13, 2024 |
Related signals
Other insiders at RALPH LAUREN CORP and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 45Moderate | sell | RL RALPH LAUREN CORP | Halide Alagoz Chief Product Officer | $1.9M | 6,724 | |
| 65Notable | sell | RL RALPH LAUREN CORP | David R. Lauren Vice Chair, Chief Innovation | $8.3M | 37,615 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.